A digital representation of the human genome. China is rapidly catching up with U.S. capabilities in biotechnology.
Trade and artificial intelligence have gotten big headlines lately, but another front is emerging as Beijing prioritizes gene-editing developments....
TO READ THE FULL ARTICLE
Copyright © Stratfor Enterprises, LLC. All rights reserved.